Creatine Shows Promise for Post-Viral Fatigue Syndrome Recovery

Post-viral fatigue syndrome (PVFS) has emerged as a significant health concern, particularly following the COVID-19 pandemic. Classified by the WHO as a neurological condition, PVFS affects an estimated 10-35% of individuals following viral infections, manifesting as persistent fatigue, cognitive difficulties, and post-exertional malaise that can last months or years.

This comprehensive review examines emerging evidence linking disrupted creatine metabolism to PVFS pathophysiology. Recent studies using advanced brain imaging techniques have revealed significantly reduced creatine levels in key brain regions and skeletal muscle of PVFS patients compared to healthy controls. These findings suggest that impaired cellular energy production, particularly through the creatine-phosphocreatine system, may be a central mechanism underlying the debilitating fatigue characteristic of this condition.

Several small clinical trials have investigated creatine supplementation as a potential therapeutic intervention. Studies involving 8-12 PVFS patients showed that daily creatine monohydrate supplementation (4g) for 3-6 months led to measurable improvements in brain and muscle creatine levels, enhanced cognitive function, reduced respiratory discomfort, and better patient-reported outcomes. Notably, these benefits occurred even without improvements in exercise tolerance, suggesting creatine's effects extend beyond simple physical performance enhancement.

The therapeutic potential of creatine appears particularly relevant given PVFS patients' often limited ability to engage in traditional rehabilitation approaches like graded exercise therapy. Creatine's excellent safety profile and accessibility make it an attractive adjunct treatment option. However, the authors emphasize that current evidence comes from small studies with modest sample sizes.

Larger, well-controlled randomized trials are urgently needed to validate these preliminary findings, establish optimal dosing protocols, and identify which patient subgroups are most likely to benefit from creatine supplementation in managing this complex and often debilitating condition.